We have been selected for the 2017 entrepreneur awards of Ernst & Young…
April, 2024. The AACR Annual Meeting in San Diego was a pivotal...
March, 2024. FIPO is the first-in-human trial of XON7, the first anti-solid...
February, 2024. For almost ten years, XENOTHERA has been committed to tackling...